雅各臣科研制药(02633)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02633 雅各臣科研制药

休市中 11-22 16:08:13

0.820

+0.020

+2.50%

最高0.830	最低0.790	成交量413.60万
今开0.800	昨收0.800	日振幅5.00%
总市值16.40亿	流通市值16.40亿	总股本20.00亿
成交额335.11万	换手率0.21%	流通股本20.00亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02633","market":"HK","secType":"STK","nameCN":"雅各臣科研制药","latestPrice":0.82,"timestamp":1732262893017,"preClose":0.8,"halted":0,"volume":4136000,"delay":0,"floatShares":2000221000,"shares":2000221000,"eps":0.139031,"marketStatus":"休市中","marketStatusCode":7,"change":0.02,"latestTime":"11-22 16:08:13","open":0.8,"high":0.83,"low":0.79,"amount":3351060,"amplitude":0.05,"askPrice":0.82,"askSize":194000,"bidPrice":0.8,"bidSize":178000,"shortable":0,"etf":0,"ttmEps":0.139,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732498200000},"adr":0,"listingDate":1474387200000,"adjPreClose":0.8,"dividendRate":0.067073,"openAndCloseTimeList":[[1732239000000,1732248000000],[1732251600000,1732262400000]],"volumeRatio":4.089502,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02633/tweets","defaultTab":"tweets","newsList":[{"id":"2485747609","title":"雅各臣科研制药将于2025年4月2日派发中期股息每股0.035港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485747609","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485747609?lang=zh_cn&edition=full","pubTime":"2024-11-22 08:45","pubTimestamp":1732236300,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　雅各臣科研制药（02633）发布公告，该公司将于2025年4月2日派发中期股息每股0.035港元。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-11-22/doc-incwwvus4026349.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-11-22/doc-incwwvus4026349.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1191","02633"],"gpt_icon":0},{"id":"2485029476","title":"雅各臣科研制药发布中期业绩 来自持续经营业务的溢利约为1.403亿港元同比增加44.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485029476","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485029476?lang=zh_cn&edition=full","pubTime":"2024-11-22 08:45","pubTimestamp":1732236300,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　雅各臣科研制药（02633）发布截至2024年9月30日止6个月的中期业绩，该集团来自持续经营业务的收益约为8.1亿港元，同比增加13.3%；来自持续经营业务的溢利约为1.403亿港元，同比增加44.2%；每股盈利7.07港仙，拟派发中期股息每股3.5港仙。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-11-22/doc-incwwvuu0803338.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-11-22/doc-incwwvuu0803338.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1191","02633"],"gpt_icon":0},{"id":"2485741707","title":"《业绩》雅各臣科研(02633.HK)中期纯利1.4亿元跌8.9%  派息3.5仙","url":"https://stock-news.laohu8.com/highlight/detail?id=2485741707","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485741707?lang=zh_cn&edition=full","pubTime":"2024-11-22 01:17","pubTimestamp":1732209420,"startTime":"0","endTime":"0","summary":"雅各臣科研制药(02633.HK) 公布9月止六个月中期业绩，收益8.1亿元，按年增加13.3%。录得纯利1.4亿元，倒退8.9%，每股盈利7.07仙。中期息3.5仙，增派1仙。(de/d)(港股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2024/06/20末期业绩股息：港元 0.03002023/11/24中期业绩股息：港元 0.02502023/06/15末期业绩股息：港元 0.02382023/06/15末期业绩实物分派: 2000股送509股 健倍苗苗（保健）有限公司 [02161]AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20240522134351581_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20240522134351581_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1398598/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1191","02633"],"gpt_icon":0},{"id":"2485461187","title":"雅各臣科研制药中期持续经营业务溢利约1.4亿港元 同比增加约44.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485461187","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485461187?lang=zh_cn&edition=full","pubTime":"2024-11-21 19:07","pubTimestamp":1732187228,"startTime":"0","endTime":"0","summary":"格隆汇11月21日丨雅各臣科研制药公告，截至2024年9月30日止6个月来自持续经营业务的收益约为8.1亿港元，较2023年同期增加约13.3%。同期来自持续经营业务的溢利约为1.4亿港元，较2023年同期增加约44.2%。香港流感自2024年1月中旬明显转趋活跃，并因流感病毒株改变而于2024年第二季度升至高峰。除季节性流感外，香港人口老化及慢性病患者增加亦推动医疗保健服务的增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121191143a24b1495&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121191143a24b1495&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02633"],"gpt_icon":0},{"id":"2485657364","title":"雅各臣科研制药(02633)发布中期业绩，来自持续经营业务的溢利约为1.403亿港元 同比增加44.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485657364","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485657364?lang=zh_cn&edition=full","pubTime":"2024-11-21 18:49","pubTimestamp":1732186161,"startTime":"0","endTime":"0","summary":"雅各臣科研制药(02633)发布截至2024年9月30日止6个月的中期业绩，该集团...","market":"sh","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_2.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_2.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1214165.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02633","BK1191"],"gpt_icon":0},{"id":"2485465438","title":"雅各臣科研制药(02633)将于2025年4月2日派发中期股息每股0.035港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485465438","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485465438?lang=zh_cn&edition=full","pubTime":"2024-11-21 18:48","pubTimestamp":1732186137,"startTime":"0","endTime":"0","summary":"智通财经APP讯，雅各臣科研制药(02633)发布公告，该公司将于2025年4月2日派发中期股息每股0.035港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1214164.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02633","BK1191"],"gpt_icon":0},{"id":"2484982526","title":"雅各臣科研制药盘中异动 早盘急速拉升5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484982526","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484982526?lang=zh_cn&edition=full","pubTime":"2024-11-18 11:04","pubTimestamp":1731899079,"startTime":"0","endTime":"0","summary":"2024年11月18日早盘11时04分，雅各臣科研制药股票出现波动，股价快速拉升5.26%。雅各臣科研制药股票所在的药品行业中，整体跌幅为0.08%。其相关个股中，中生联合、三爱健康集团、雅各臣科研制药涨幅较大，振幅较大的相关个股有天大药业、雅各臣科研制药、凯莱英，振幅分别为13.71%、7.89%、5.45%。雅各臣科研制药公司简介：雅各臣科研制药有限公司是一家从事非专利药及中成药制造及买卖的香港公司。目前该分部业务主要在中国香港开展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118110440971a70b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118110440971a70b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02633"],"gpt_icon":0},{"id":"2483040976","title":"雅各臣科研制药盘中异动 股价大跌5.33%报0.710港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483040976","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483040976?lang=zh_cn&edition=full","pubTime":"2024-11-13 14:57","pubTimestamp":1731481077,"startTime":"0","endTime":"0","summary":"2024年11月13日下午盘14时57分，雅各臣科研制药股票出现异动，股价大幅跳水5.33%。截至发稿，该股报0.710港元/股，成交量72.8万股，换手率0.04%，振幅5.33%。雅各臣科研制药股票所在的药品行业中，整体跌幅为0.39%。目前该分部业务主要在中国香港开展。消息层面，截至14时57分，《雅各臣科研制药：Po Chai Herbal及PCHT与欧化药业订立买卖协议》资讯为影响雅各臣科研制药的重要信息。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111314575898e424af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111314575898e424af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02633"],"gpt_icon":0},{"id":"2482573332","title":"雅各臣科研制药拟4623万港元收购李众胜堂(集团)约10万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2482573332","media":"格隆汇","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482573332?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:47","pubTimestamp":1731336423,"startTime":"0","endTime":"0","summary":"格隆汇11月11日丨雅各臣科研制药及健倍苗苗公告，于2024年11月11日，健倍苗苗的间接全资附属公司Po Chai Herbal及健倍苗苗的间接全资附属公司PCHT与雅各臣的间接全资附属公司欧化药业订立买卖协议，据此，Po Chai Herbal及PCHT有条件同意分别出售56,500股及44,000股销售股份，而欧化药业有条件同意收购有关李众胜堂(集团)有限公司的100,500股股份，总代价为4623万港元。科技园已批准该安排，原因为目标公司为欧化药业同系附属公司，因而属科技园租赁下的获许可实体。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111225136a22ceebd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111225136a22ceebd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02633","BK1191"],"gpt_icon":0},{"id":"2482233787","title":"雅各臣科研制药(02633)：Po Chai Herbal及PCHT与欧化药业订立买卖协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2482233787","media":"智通财经","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482233787?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:18","pubTimestamp":1731334693,"startTime":"0","endTime":"0","summary":"智通财经APP讯，雅各臣科研制药 与健倍苗苗发布联合公告，于2024年11月11日，Po Chai Herbal及PCHT与欧化药业订立买卖协议，Po Chai Herbal及PCHT有条件同意分别出售5.65万股及4.4万股销售股份，而欧化药业有条件同意收购有关销售股份，总代价为4623万港元。于本联合公告日期，Po Chai Herbal及PCHT均为健倍苗苗的间接全资附属公司，而欧化药业为雅各臣的间接全资附属公司。公告称，该许可安排为欧化药业带来未使用工厂空间的租金收入，亦为目标公司提供合适制造场地。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1209528.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1585","BK1191","BK1201","01711","02633"],"gpt_icon":0},{"id":"2481913073","title":"雅各臣科研制药(02633)上涨10.29%，报0.75元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2481913073","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481913073?lang=zh_cn&edition=full","pubTime":"2024-11-07 11:12","pubTimestamp":1730949172,"startTime":"0","endTime":"0","summary":"11月7日，雅各臣科研制药(02633)盘中上涨10.29%，截至11:12，报0.75元/股，成交285.78万元。雅各臣科研制药有限公司主要致力于药品的研发、生产、分销、销售和物流等业务，提供非专利药和中药的生产制造，并在亚洲市场拥有广泛的销售和分销网络。公司拥有超过1500名员工，设有多个经欧盟PIC/S GMP认证的生产设施以及自有仓库，配备SAP系统以提供高效灵活的物流方案。截至2023年年报，雅各臣科研制药营业总收入13.31亿元、净利润2.42亿元。11月6日，预计2024年中报业绩预增，溢利同比增长40%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/07111245024775.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1191","02633"],"gpt_icon":0},{"id":"2481947099","title":"【盈喜股】雅各臣科研制药(02633)涨4.41% 料上半财年持续经营业务溢利按年升逾4成","url":"https://stock-news.laohu8.com/highlight/detail?id=2481947099","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481947099?lang=zh_cn&edition=full","pubTime":"2024-11-07 09:58","pubTimestamp":1730944729,"startTime":"0","endTime":"0","summary":"金吾财讯 | 雅各臣科研制药 盈喜后股价向好，截至发稿，涨4.41%，报0.71港元，成交额133.5万港元。公司日前发布盈喜，预期集团截至2024年9月30日止六个月录得来自持续经营业务的溢利较去年同期增加超过40%。来自持续经营业务的期内溢利大幅增加主要归因于公私营界别非专利药业务的稳健业绩，以及新获授权产品和新产品强劲推出所带来的收益贡献。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241105/ODRiNTNiMzllYTJiOGU4YWE0NGY4MzY3NjA4Mjk3MDA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241105/ODRiNTNiMzllYTJiOGU4YWE0NGY4MzY3NjA4Mjk3MDA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1947256","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02161","BK1191","BK1606","02633"],"gpt_icon":0},{"id":"2481994547","title":"雅各臣科研制药早盘涨超4% 预计中期溢利同比增超40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481994547","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481994547?lang=zh_cn&edition=full","pubTime":"2024-11-07 09:49","pubTimestamp":1730944140,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　雅各臣科研制药（02633）发盈喜后高开，股价上涨4.41%，现报0.71港元，成交额108.50万港元。\n　　雅各臣科研制药发布公告，集团预期，截至2024年9月30日止6个月取得来自持续经营业务的溢利较去年同期增加超过40%。来自持续经营业务的期内溢利大幅增加主要归因于公私营界别非专利药业务的稳健业绩，以及新获授权产品和新产品强劲推出所带来的收益贡献。生产设施经营杠杆提升及因有效成本控制措施而节省相应开支亦推动相关增长。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-11-07/doc-incvexch9396223.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-11-07/doc-incvexch9396223.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1191","02633"],"gpt_icon":0},{"id":"2481326994","title":"雅各臣科研制药盘中异动 早盘股价大涨5.88%报0.720港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481326994","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481326994?lang=zh_cn&edition=full","pubTime":"2024-11-07 09:30","pubTimestamp":1730943010,"startTime":"0","endTime":"0","summary":"2024年11月07日早盘09时30分，雅各臣科研制药股票出现异动，股价快速上涨5.88%。截至发稿，该股报0.720港元/股，成交量94.2万股，换手率0.05%，振幅1.47%。雅各臣科研制药股票所在的药品行业中，整体跌幅为0.08%。其相关个股中，雅各臣科研制药、四环医药、远大医药涨幅较大，振幅较大的相关个股有石药集团、复星医药、雅各臣科研制药，振幅分别为1.69%、1.57%、1.47%。目前该分部业务主要在中国香港开展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107093010a21e5c9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107093010a21e5c9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02633"],"gpt_icon":0},{"id":"2481995739","title":"港股异动 | 雅各臣科研制药(02633)盈喜后高开逾4% 预计中期溢利同比增超40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481995739","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481995739?lang=zh_cn&edition=full","pubTime":"2024-11-07 09:24","pubTimestamp":1730942643,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，雅各臣科研制药盈喜后高开逾4%，截至发稿，涨4.41%，报0.71港元，成交额65.32万港元。消息面上，雅各臣科研制药发布公告，集团预期，截至2024年9月30日止6个月取得来自持续经营业务的溢利较去年同期增加超过40%。由于在实物分派健倍苗苗(保健)有限公司股份作为特别股息后，公司不再将健倍苗苗及其附属公司的业绩于财务报表综合入账，预期中期期间公司权益持有人应占溢利较去年同期轻微下降不多于9%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1207781.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02161","BK1191","BK1606","02633"],"gpt_icon":0},{"id":"2481778993","title":"【湾区早参】深圳七大产业基金遴选管理机构；广州成首个上调房贷利率下限城市","url":"https://stock-news.laohu8.com/highlight/detail?id=2481778993","media":"金吾财讯","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481778993?lang=zh_cn&edition=full","pubTime":"2024-11-07 08:42","pubTimestamp":1730940140,"startTime":"0","endTime":"0","summary":"业内人士认为， 广州是当前楼市回稳态势下首个上调房贷利率下限的城市，做法有一定的风向标意义。","market":"hk","thumbnail":"https://static.szfiu.com/news/20230515/ZGJkOWM1Nzk2NTY2M2QxMDEzMTU3MjkwNTIx.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20230515/ZGJkOWM1Nzk2NTY2M2QxMDEzMTU3MjkwNTIx.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1947235","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["80175","02161","80388","02601","LU0164880469.USD","LU0043850808.USD","BK1119","00388","LU0873338254.USD","LU0516422952.EUR","BK1606","LU1105468828.SGD","02633","HKXCY","LU0516422366.SGD","LU1366334578.USD","LU0572944931.SGD","LU0287142896.SGD","LU0577902298.EUR","LU0918141705.HKD","00081","LU0048597586.USD","02518","LU0918141887.USD","LU1226287529.USD","LU0251144936.SGD","LU0577902611.USD","LU0540923850.HKD","03121","LU0348735423.USD","LU0048580855.USD","EVS.SI","LU1044875133.USD","00175","00688","LU0501845795.SGD","LU1655091616.SGD","GELYY","02038","LU0329678170.USD","LU0348814723.USD","BK1555","BK1550","BK1508","LU0456846285.SGD","BK1589","LU0173614495.USD","LU0594300419.USD","LU0791591158.USD","SG9999001226.SGD"],"gpt_icon":1},{"id":"2481196721","title":"智通港股早知道 | 特朗普宣布赢得2024年美国总统选举 华为公布最新的硫化物固态电池专利","url":"https://stock-news.laohu8.com/highlight/detail?id=2481196721","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481196721?lang=zh_cn&edition=full","pubTime":"2024-11-07 07:50","pubTimestamp":1730937020,"startTime":"0","endTime":"0","summary":"华为公布最新的硫化物固态电池专利11月5日，华为公布最新的硫化物固态电池专利，名称为《掺杂硫化物材料及其制备方法、锂离子电池》。此前的10月8日以及9月3日，比亚迪也公布了两大固态电池专利。公告显示，本次举牌前，中邮保险直接持有皖通高速H股股票2454.4万股，占其H股股本比例为4.9784%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1207748.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1610","BK1606","159796","BK1588","BK1567","01712","BABA","BK1587","NVDA","YANG","BK1191","BK1575","LU0593848301.USD","TSLA","02633","DJT","BK1119","HSCEI","BK1185","BK1198","00995","HSTECH","02161","BK1539"],"gpt_icon":1},{"id":"2481261056","title":"雅各臣科研制药(02633)发盈喜 预计中期溢利同比增加超过40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481261056","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481261056?lang=zh_cn&edition=full","pubTime":"2024-11-06 16:35","pubTimestamp":1730882142,"startTime":"0","endTime":"0","summary":"雅各臣科研制药(02633)发布公告，集团预期，截至2024年9月30日止6个月取...","market":"hk","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_45.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_45.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1207411.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1191","02633"],"gpt_icon":0},{"id":"2481629319","title":"《盈喜》雅各臣科研制药(02633.HK)料半年持续经营业务溢利按年升逾40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481629319","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481629319?lang=zh_cn&edition=full","pubTime":"2024-11-06 16:35","pubTimestamp":1730882100,"startTime":"0","endTime":"0","summary":"雅各臣科研制药(02633.HK) 发盈喜，料截至今年9月底，来自持续经营业务的半年溢利较去年同期增加超过40%，主要归因于公私营界别非专利药业务的稳健业绩，以及新获授权产品和新产品强劲推出所带来的收益贡献。生产设施经营杠杆提升及有效成本控制措施亦推动相关增长。公司表示，由于在实物分派健倍苗苗(02161.HK) 股份作为特别股息后，公司不再将健倍苗苗及其附属公司的业绩入账，预期中期期间公司权益持有人应占溢利较去年同期轻微下降不多于9%。(vc/u)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20240522134351581_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20240522134351581_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1394618/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1191","02633"],"gpt_icon":0},{"id":"2477871211","title":"上市公司炒股也疯狂，有公司亏完半年营收继续砸钱入市｜钛媒体焦点","url":"https://stock-news.laohu8.com/highlight/detail?id=2477871211","media":"钛媒体APP","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477871211?lang=zh_cn&edition=full","pubTime":"2024-10-22 13:52","pubTimestamp":1729576327,"startTime":"0","endTime":"0","summary":"近来的A股行情火爆，散户跑步入市，一同抱钱杀入的还有中国A股上市公司。10月19日，新城市（300778.SZ）、中兴商业（000715.SZ）双双公告拟进行证券投资，前者额度是不超过2亿元，后者则是在2023年12月5000万元额度上追加了7000万元资金。钛媒体APP梳理发现，始于国庆前的一波行情直接将市场预期拉满，上市公司入市的热情明...","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/OrPMIO0832E9eSbP46Qw9ugMfWKe1iyRWz58dp9HMQCl0AA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OrPMIO0832E9eSbP46Qw9ugMfWKe1iyRWz58dp9HMQCl0AA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241022A04MAX00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241022A04MAX00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["LU0345775950.USD","BK1161","LU1813983027.USD","LU0348827113.USD","BK1574","LU1023057109.AUD","LU2097828474.EUR","BK1575","LU0359201885.HKD","LU1770036033.HKD","LU1328277881.USD","LU1770034418.SGD","LU2097828714.EUR","LU0348825331.USD","LU0611395673.USD","LU0417516902.SGD","81810","BK1523","LU2097828805.USD","LU2039709279.SGD","BK1606","LU2097828631.EUR","LU0345776255.USD","BK1506","LU0359202008.SGD","LU0359201612.USD","03681","SG9999002463.SGD","BK1589","02633","02161","BK1521","BK1607","LU0314109678.HKD","BK1193","LU0561508036.HKD","BK1191","LU2097828557.USD","BK1502"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.jacobsonpharma.com","stockEarnings":[{"period":"1week","weight":0.0789},{"period":"1month","weight":0.3016},{"period":"3month","weight":0.4882},{"period":"6month","weight":0.4617},{"period":"1year","weight":0.4236},{"period":"ytd","weight":0.3465}],"compareEarnings":[{"period":"1week","weight":-0.0101},{"period":"1month","weight":-0.0737},{"period":"3month","weight":0.0919},{"period":"6month","weight":0.0334},{"period":"1year","weight":0.0736},{"period":"ytd","weight":0.128}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"雅各臣科研制药有限公司是一家从事非专利药及中成药制造及买卖的香港公司。该公司通过两大分部运营。非专利药分部开发、生产及分销作治疗用途非专利药。目前该分部业务主要在香港开展。中成药分部开发、制造及分销中药。目前该分部业务主要在香港开展。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":-0.013832},{"month":2,"riseRate":0.25,"avgChangeRate":0.010092},{"month":3,"riseRate":0.25,"avgChangeRate":-0.067789},{"month":4,"riseRate":0.375,"avgChangeRate":-0.020875},{"month":5,"riseRate":0.75,"avgChangeRate":0.004514},{"month":6,"riseRate":0.625,"avgChangeRate":0.035049},{"month":7,"riseRate":0.25,"avgChangeRate":-0.043833},{"month":8,"riseRate":0.625,"avgChangeRate":0.025944},{"month":9,"riseRate":0.25,"avgChangeRate":-0.010667},{"month":10,"riseRate":0.111111,"avgChangeRate":-0.054309},{"month":11,"riseRate":0.555556,"avgChangeRate":0.048452},{"month":12,"riseRate":1,"avgChangeRate":0.126249}],"exchange":"SEHK","name":"雅各臣科研制药","nameEN":"JACOBSON PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"雅各臣科研制药(02633)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供雅各臣科研制药(02633)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"雅各臣科研制药,02633,雅各臣科研制药股票,雅各臣科研制药股票老虎,雅各臣科研制药股票老虎国际,雅各臣科研制药行情,雅各臣科研制药股票行情,雅各臣科研制药股价,雅各臣科研制药股市,雅各臣科研制药股票价格,雅各臣科研制药股票交易,雅各臣科研制药股票购买,雅各臣科研制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"雅各臣科研制药(02633)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供雅各臣科研制药(02633)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}